Central nervous system disorder
Therapeutic area
Neurology
Rare disease
No
- Definition
- A disease involving the central nervous system.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Central nervous system disorder
- Therapeutic area
- Neurology
- central nervous system disorder
- CNS disorder
- central nervous disease
- central nervous system disease
- central nervous system disease or disorder
- central nervous system disorder
- disease of central nervous system
- disease of the central nervous system
- disease or disorder of central nervous system
- disorder of central nervous system
- All therapeutic areas
- Neurology
- Severity
- Unknown
- MONDO ID
- MONDO:0002602
- Parent condition
- MONDO:0005071
Related records
Broader conditions (4)
- Disease
- Disease by body system or component
- Human disease
- Nervous system disorder
Narrower conditions (2,560)
- AARS1-related leukoencephalopathy
- ABeta amyloidosis, Arctic type
- ABeta amyloidosis, dutch type
- ABeta amyloidosis, Iowa type
- ABeta amyloidosis, Italian type
- ABetaA21G amyloidosis
- ABetaL34V amyloidosis
- Abetalipoproteinemia
- ABri amyloidosis
- Aceruloplasminemia
- ACO2-related optic atrophy with or without extraocular features
- Acquired aneurysmal subarachnoid hemorrhage
- Acquired Creutzfeldt-Jakob disease
- Acquired developmental and epileptic encephalopathy
- Acquired human prion disease
- Acquired hyperprolactinemia
- Acquired motor neuron disease
- Acquired pituitary hormone deficiency
- Acquired porencephaly
- Acquired schizencephaly
Trials (418)
- 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
- 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults
- 1H Magnetic Resonance Spectroscopy in Migraine Patients
- 2-Part Multiple Ascending Dose Study for Safety and Pharmacokinetics in Healthy and Elderly Subjects
- 4D-310 in Adults With Fabry Disease and Cardiac Involvement
- A 2-Period Crossover Study of BPN14770 in Adults Males With Fragile X Syndrome
- A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Donepezil Hydrochloride in Chinese Subjects With Severe Alzheimer's Disease
- A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population
- A Clinical Study to Evaluate the Drug Interaction Between YZJ-1139 Tablets and Escitalopram Oxalate Tablets
- A Clinical Trial of PRAX-114 in Participants With Essential Tremor
- A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria
- A Drug-drug Interaction Study of Avapritinib and Midazolam
- A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease
- A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)
- A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- A Longitudinal Study of Amyotrophic Lateral Sclerosis (ALS) Biomarkers
- A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
- A Multicenter Study of Ultrafast Pulse Wave Velocity in Obese Chinese Han Adults
- A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)
Drugs in development (10)
- Donepezil Phase 1
- Encenicline Phase 1
- Enzastaurin Phase 1
- Gadobutrol Phase 3
- Gadopiclenol Phase 2
- Gadoterate meglumine Phase 3
- Gadoteridol Phase 3
- Memantine Phase 1
- Rivastigmine Phase 1
- Tasadenoturev Phase 1
Other linked drugs (5)
- Gadodiamide
- Metrizamide
- Protirelin
- Taltirelin
- Technetium TC 99M bicisate